Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver Metastases. Li J, Waller G, Qin Y, Yu AT, et al. Ann Surg Oncol 2026;33:1448-1459.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li J, Waller G, Qin Y, Yu AT, et al. Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver Metastases. Ann Surg Oncol 2026;33:1448-1459.
PMID: 41083826